Baseline Characteristics and Initial Safety Results in RESPOND: A Phase 4 Study of Nusinersen in Children with Spinal Muscular Atrophy (SMA) Who Received Onasemnogene AbeparvovecJohn Brandsema,Julie Parsons,Crystal Proud,Richard Finkel,Kathryn Swoboda, Ricardo Masson,Yingying Liu,Corinne Makepeace, Angela Paradis,Zdenek Berger, Joanne Wagner,Kathleen Somera-MolinaNEUROLOGY（2022）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
